Redwood Park Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.46K Hold
67
0.01% 188
2026
Q1
$9.27K Sell
67
-7
-9% -$980 0.01% 179
2025
Q4
$9.11K Hold
74
0.01% 176
2025
Q3
$8.19K Buy
74
+1
+1% +$114 0.01% 180
2025
Q2
$8.14K Buy
73
+16
+28% +$1.7K 0.01% 177
2025
Q1
$6.39K Hold
57
0.01% 194
2024
Q4
$5.27K Buy
+57
New +$5.13K ﹤0.01% 204

Other funds holding GILD

Redwood Park Advisors's GILD Position: Q2 2026 in Review

Redwood Park Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 67 shares worth $8.46K. The position accounts for 0.01% of the portfolio, ranked #188.

Redwood Park Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.27K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Redwood Park Advisors held 67 shares of Gilead Sciences worth $8.46K as of Q2 2026.
  • Redwood Park Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Redwood Park Advisors's portfolio in Q2 2026, its #188 holding.
  • Redwood Park Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Redwood Park Advisors's Gilead Sciences position peaked at $9.27K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.